The IPO Market Has the Best of Times in the Worst of Times
2020 was a year to forget for many people, but it was unforgettable for IPO investors who benefitted from both the number of IPOs and their outsized average returns. While the COVID-19 pandemic sent global markets into a
Crucible Acquisition, a blank check company formed by Foundry Group and a former Splunk executive targeting tech, raised $225 million by offering 22.5 million units at $10. The company offered 2.5 million more units than anticipated. Each unit consists of one share of c
Benessere Capital Acquisition, a blank check company targeting middle market technology businesses in the Americas, raised $100 million by offering 10 million units at $10. Each unit will consist of one share of common stock and three-fourths of a warrant, exercisable at $11.50.
Fortress Value Acquisition III, the third blank check company formed by executives at Fortress Investment Group, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one-fifth of a warrant, exercisable at $11.50.
The compan
Fortress Value Acquisition III, the third blank check company formed by executives at Fortress Investment Group, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one-fifth of a warrant, exercisable at $11.50.
The compan
European Sustainable Growth Acquisition, a blank check company targeting European sustainability businesses, filed on Monday with the SEC to raise up to $125 million in an initial public offering.
The Greenwich, CT-based company plans to raise $125 million by offering 12.5 milli
RMG Acquisition III, the third blank check company formed by Riverside's James Carpenter and former Carlyle executive Robert Mancini, filed on Monday with the SEC to raise up to $350 million in an initial public offering.
The New York, NY-based company plans to raise $350 millio
North Atlantic Acquisition, a blank check company targeting the consumer, industrials, and telecom sectors in North America and Europe, filed on Monday with the SEC to raise up to $300 million in an initial public offering.
The New York, NY-based company plans to raise $300 mill
Big Cypress Acquisition, a blank check company targeting life science businesses in the US and Israel, raised the proposed deal size for its upcoming IPO on Monday.
The Miami Beach, FL-based company now plans to raise $100 million by offering 10 million units at $10. The company
Ortho Clinical Diagnostics, a Carlyle-backed global provider of in vitro diagnostic products, filed on Monday with the SEC to raise up to $100 million in an initial public offering. However, this is likely a placeholder for a deal we estimate could raise up to $800 million.
Cardiva Medical, which makes minimally invasive catheter-based vascular closure devices, filed on Monday with the SEC to raise up to $75 million in an initial public offering.
Cardiva's devices are designed around an easy to use, catheter-based delivery system and the natural cl
Cardiva Medical, which makes minimally invasive catheter-based vascular closure devices, filed on Monday with the SEC to raise up to $75 million in an initial public offering.
Cardiva's devices are designed around an easy to use, catheter-based delivery system and the natural cl
Vinci Partners Investments, an alternative asset manager in Brazil, filed on Monday with the SEC to raise up to $100 million in an initial public offering.
Vinci Partners' filing comes on the heels of Brazilian private equity firm Patria Investments' (PAX) IPO filing last week.&
Vinci Partners Investments, an alternative asset manager in Brazil, filed on Monday with the SEC to raise up to $100 million in an initial public offering.
Vinci Partners' filing comes on the heels of Brazilian private equity firm Patria Investments (PAX). The company's&nbs
Gracell Biotechnologies, a Phase 1 Chinese biotech developing CAR-T cell therapies for cancer, announced terms for its US IPO on Monday.
The Suzhou, China-based company plans to raise $150 million by offering 8.8 million ADSs at a price range of $16 to $18. At the midpoint of th
AmeriHome, a residential mortgage producer and servicer, revived its IPO plans on Monday with a blank filing after postponing its $250 million IPO in October 2020. In its latest filing, the company disclosed updated financials for the nine months ended September 30, 202
Cullinan Management, a Phase 1/2a biotech developing and investing in oncology therapies, announced terms for its IPO on Monday.
The Cambridge, MA-based company plans to raise $150 million by offering 8.3 million shares at a price range of $17 to $19. Existing shareholders
Cullinan Oncology, a Phase 1 biotech developing targeted oncology and immuno-oncology therapies, announced terms for its IPO on Monday.
The Cambridge, MA-based company plans to raise $150 million by offering 8.3 million shares at a price range of $17 to $19. At the midpoint of t
Hudson Executive Investment II, the second blank company formed by Hudson Executive Capital targeting high-growth industries, filed on Thursday for an initial public offering.
The New York, NY-based company plans to raise $200 million by offering 20 million units at a price of $
Bridgetown 2 Holdings, the second blank check company formed by Pacific Century and Thiel Capital targeting new economy sectors in Southeast Asia, filed on Thursday with the SEC for an initial public offering.
The Hong Kong, China-based company plans to raise $200 million by off